![Philippe Motté](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Philippe Motté
Gründer bei
Celestial Consulting & Coaching
Profil
Philippe Motté is the founder of Celestial Consulting & Coaching, which was founded in 2018.
He currently holds the title of President at Celestial Consulting & Coaching.
Mr. Motté is also currently a Member at Académie nationale de Pharmacie.
In his former positions, Mr. Motté served as the Chief Regulatory & Quality Officer at Genfit SA from 2021 to 2022, and as the Chief Access Officer at MedDay Pharmaceuticals SAS from 2019 to 2020.
He also held the position of Senior Vice President-Regulatory & Quality at Gensight Biologics SA. Mr. Motté obtained an MBA from ESCP Europe Campus London and holds doctorate degrees from Universite Paris Cite and Université Paris-Saclay.
Aktive Positionen von Philippe Motté
| Unternehmen | Position | Beginn |
|---|---|---|
Celestial Consulting & Coaching | Gründer | 01.06.2018 |
Académie nationale de Pharmacie | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Philippe Motté
| Unternehmen | Position | Ende |
|---|---|---|
| GENFIT | General Counsel | 01.08.2022 |
MedDay Pharmaceuticals SAS
 MedDay Pharmaceuticals SAS BiotechnologyHealth Technology Operates as a biotechnology company developing new drugs for nervous system disorders | Corporate Officer/Principal | 01.06.2020 |
| GENSIGHT BIOLOGICS S.A. | General Counsel | - |
Ausbildung von Philippe Motté
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
2
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Genfit SA
 Genfit SA BiotechnologyHealth Technology Engages in research and development of medicines and diagnostic solutions | Health Technology |
Gensight Biologics SA
 Gensight Biologics SA Pharmaceuticals: MajorHealth Technology Manufactures and markets novel therapies for severe retinal neurodegenerative diseases | Health Technology |
MedDay Pharmaceuticals SAS
MedDay Pharmaceuticals SAS BiotechnologyHealth Technology Operates as a biotechnology company developing new drugs for nervous system disorders | Health Technology |
Académie nationale de Pharmacie | |
ESCP Europe Campus London
 ESCP Europe Campus London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universite Paris Cite
 Universite Paris Cite Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université Paris-Saclay
 Université Paris-Saclay Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celestial Consulting & Coaching |
